Torrent Pharmaceuticals has completed acquisition of branded businesses of Unichem Laboratories Limited for India and Nepal, including its Sikkim manufacturing facility.

Torrent Pharma stated, “From today, Torrent begins the integration of the Unichem business following the successful closure of its acquisition. The integration will aim to fuel and support strong growth of the acquired Unichem brands, consolidating specialty reach with a relentless focus on enhancing productivity. The acquisition will accelerate Torrent’s presence in the chronic space especially in the high growth segments of Indian Pharma market like Cardiology, Diabetology and Gastroenterology. Moreover, Unichem brings in an important new platform in Torrent’s sustainable growth strategy by expanding the Company’s presence in the OTC segment.”

Moreover, this acquisition is done by way of, on going concern basis by way of slump sale.

Read EquityPandit’s Technical Analysis on Nifty Pharma